An iridium complex for dynamic detection of mitochondrial viscosity and tumor differentiation, and a preparation method and use thereof
By designing the iridium complex Ir-visc and utilizing a double-lock mitochondrial targeting strategy and positive charge binding, the problem of existing probes' dependence on membrane potential was solved, achieving efficient mitochondrial viscosity monitoring and cancer diagnosis, and possessing deep tissue imaging capabilities.
Patent Information
- Application Number
- CN202411840668.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-13
- Publication Date
- 2025-10-14
- Estimated Expiration
- 2044-12-13
AI Technical Summary
Existing mitochondrial viscosity probes are highly dependent on mitochondrial membrane potential, have short luminescence lifetime and insufficient tissue penetration depth, which limits their application in cancer diagnosis and biological research.
An iridium complex, Ir-visc, was designed. Through a double-lock mitochondrial targeting strategy, C^N and N^N ligands modified with benzothiazole derivatives and electron-rich thiophene rings were used to combine positive charges with non-covalent bonds to mitochondrial membrane proteins, achieving high quantum yield of viscosity activation and deep tissue imaging.
It achieves stable monitoring of mitochondrial viscosity and tumor differentiation, has high quantum yield, long luminescence lifetime and deep tissue penetration ability, can effectively distinguish cancer cells from normal cells, and provides multi-level visualization tools.